USA Lobbying on Healthcare - Washington (Q2 2026)
Bristol-Myers Squibb, Pharmaceutical Research and Manufacturers of America, Pfizer Inc, Genentech Inc, Eli Lilly & Co, Vertex Pharmaceuticals were unusually active lobbyists this quarter.
Read next
This Week in Healthcare — Washington (#31, 2026)
ALS therapies bill advances; mammography coverage proposal introduced; device reprocessing study bill filed; EMS memorial extension bill action; diabetes prevention reauthorization bill referred.
USA Lobbying on Mining - Washington (Q2 2026)
Glencore LTD, Cleveland-cliffs INC, Uranium Energy Corp, National Mining Assn, Us Strategic Metals were unusually active lobbyists this quarter.
USA Lobbying on Utilities & Power - Washington (Q2 2026)
PG&E Corp, NextEra Energy, Edison Electric Institute, Avangrid Inc, Tri-State Generation & Transmission Assn, Pacific Gas and Electric Company were unusually active lobbyists this quarter.